News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CEL-SCI (CVM) Announces That NYSE MKT Granted an Extension to Regain Compliance


10/4/2013 9:53:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT:CVM) announces that the NYSE MKT (the “Exchange”) has granted the Company an extension until October 31, 2013 to regain compliance with the Exchange’s continued listing standards. The Exchange initially granted the Company until September 30, 2013 to regain compliance after accepting the Company’s plan on August 30, 2013 to bring itself into compliance.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES